Zonisamide for progressive myoclonus epilepsy: Long-term observations in seven patients

Epilepsy Research

Volumn 29, Issue 2, 1998, Pages 109-114

  Kyllerman, Mårten ^a   Ben Menachem, Elinor ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Progressive myoclonic epilepsies; Unverricht Lundborgs disease; Zonisamide

Indexed keywords

ACETAZOLAMIDE; ACETYLCYSTEINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; MULTIVITAMIN; PHENOBARBITAL; RIBOFLAVIN; SELENIUM; VALPROIC ACID; ZINC; ZONISAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; MALE; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0031962476     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00069-7     Document Type: Article

References (16)

1. Berkovic SF, Cochius J, Andermann E, Andermann F Progressive myoclonus epilepsies: Clinical and genetic aspects. Epilepsia. 34(suppl 3):1993;S19-30.
2. Yamakawa K, Mitchell S, Hubert R, Chen X-N, Colbern S, Huo Y-Ket al. Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum Mol Genet. 4:1995;709-716.
3. Serratosa JM, Delgado-Escueta A, Posada I, Shih S, Drury I, Berciano J, Zabala JA, Sparkes RS The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosone 6q. Hum Mol Genet. 4:1995;1657-1663.
4. Iivanainen M, Himberg JJ Valproate and clonazepam in the treatment of severe progressive myoclonusepilepsy. Acta Neurol. 39:1982;236-238.
5. Henry TR, Leppik IE, Gummit RJ, Jacobs M Progressive myoclonus epilepsy treated with zonisamide. Neurology. 38:1982;928-931.
6. Kyllerman M, Sommerfeldt K, Hedström A, Wennergren G, Holmgren D Clinical and neurophysiological development of Univerricht-Lundborg Disease in four Swedish siblings. Epilepsia. 32:1991;900-909.
7. Lundborg H. Klinische studier und erfahrungen hinsichtlich der familiaren myoklonie und damn' verwandter krankheiten. Stockholm: Issac Marcus Boktr-Aktiebolag, 1901.
8. Lehesioki AK, Koskiniemi M, Pandolfo M, Antonielli A, Kyllerman Met al. Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's disease. Neurology. 42:1992;1545-1550.
9. Oguni H, Hayashi K, Fukuyama Y, et al. Phase III study of a new antiepileptic AD-810, zonisamide in childhood epilepsy. Jap J Pediatr (in Japanese) 41;1988:439-450.
10. Pennacchio LA, Lehesjoki AK, Stone NE, Willour VL, Virtaneva K, Miao Jet al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy. Science. 217:1996;1731-1734.
11. Seino M, Okuma T, Miyazaka M, et al. Efficacy evaluation of AD-810 (zonisamide). Double-blind study comparing with carbamazepine. J Clin Exp Med. 1988;144:275-291 (in Japanese).
12. Seino M, Naruto S, Tsugutaka I, Miyazaki H. Other antiepileptic drugs: Zonisamide. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs. 4th edn. New York: Raven Press, 1995:1011-1023.
13. Eldridge R, Iivanainen M, Stern R, Joerber T, Wilder BJ 'Baltic' myoclonic epilepsy: H hereditary disorder of childhood made worse by phenytoin. Lancet. 2:1983;838-842.
14. Schmidt D., Jacob R., Loiseau P.et al. Zonisamide for add-on treatment of refractory partial epilepsy: A European double-blind trial. Epilepsy Res. 15:1993;67-73.
15. Leppik IE, Willmore LJ, Homan RW, Fromm G, Oommen KJ, Penry JK, Sackellares JC, Smith DB, Lesser RP, Wallace JD, Trudeau JL, Lamoreaux LK, Spenser M Efficacy and safety of zonisamide: Results of a multicenter study. Epilepsy Res. 14:1993;165-173.
16. Wilder BJ, Ramsay RE, Guterman A, et al. A double-blind multicenter placebo-controlled study of the efficacy and safety of zonisamide in the treatment of complex partial seizures in medically intractable patients. Internal report of Dainippon Pharmaceutical, 1986.